Sterling Healthcare Limited A Sandesara Group Company

Sterling Healthcare Limited ( A Sandesara Group Company) Company Presentation 3/19/2018 1

Pharmaceuticals Engineering Infrastructure Oil & Gas Healthcare Sandesara Group Business interests in: Healthcare, Oil & Gas, Infrastructure, Engineering, Pharmaceuticals 3/19/2018 2

Vision To become a global player in generic pharmaceutical business with: Supply of Quality Drugs Strategic Alliances Joint Ventures 3/19/2018 3

Plant Overview Pharmaceutical Contract Manufacturing of Oral Solid Dosage Formulations (Tablet / Capsule / Granules) l Plot Size: 21, 000 m² l Facility with built-up area of 5, 077 m² 3/19/2018 4

Location Layout Corporate Office Mumbai Urse, Talegaon Sterling Healthcare Limited 3/19/2018 API Manufacturing Facility Baroda 5

Site Layout 3/19/2018 6

Regulatory Status : § Audited & Approved by Germany (July 2013) § Audited & Approved by WHO, CDSCO (February 2012) § Audited & approved by MOH, Namibia (August 2010) 3/19/2018 7

Approvals WHO GMP Certificate 3/19/2018 EU GMP Certificate 8

Approvals Republic of Namibia GMP Certificate 3/19/2018 9

Organogram Mr. Satish Shah CEO Mr. Sanjay Amla VP -Operations Mr. Laxman Gaddamwar DGM -Operations Mr. Prasanna Wagh Asst. Manager Warehouse Mr. Sushim Jain Manager Engineering Mr. Rajendra Nehete Sr. GM-Quality Mr. Vilas Kharat Sr. Manager -HR Mr. Manojkumar Sahu Head -QA Mrs. Chanda Peshave Sr. Manager. Accounts/Purchase Officer-04 Officer 02 Executive -02 Executive-04 Mr. Kedar Athalye Sr. Executive Microbiology Executive-03 Officer-02 Officer-07 Trainee-03 Officer-04 Executive-01 Mr. Sikander Shaikh Sr. Executive -QC Officer-09 Execuive-04 Executive-02 Mr. Bhauso Vhanmane Asst. Manager-QA Execdutive-03 Mr. Bhaskar Joshi Manager Production Trainee-06 Officer -02 Technician-07 Trainee-08 Technician-18 3/19/2018 10

Facility & Capacity Two granulation suites (Approx. 219 Sq. m) l Two blending suites ( Approx. 47 Sq. m) l Four compression areas ( Approx. 130 Sq. m) l Two encapsulation areas ( Approx. 80 Sq. m) l Two coating areas (Approx. 124 sq. m) l Five packaging lines : 4 Blister and 1 CAPACITIESPacking ( Approx. 134 sq. m) Per month Per annum Bulk l (Single Shift) (Million) Tablets 110 1300 Capsules 15 180 Blister Packing 65 780 Sachet Packing 0. 33 3. 6 3/19/2018 11

Tablet Manufacturing l l Granulation : 1200 kg / shift ( 2 granulation suites) Blending : 1680 kg / shift ( 2 blenders ) Compression Machine Coating Machine Equipment Capacity Make Rapid Mixer Granulator 180 -480 Liters Saral Engineering Fluid Bed Drier 250 Kgs Saral Engineering Fluid Bed Processor 500 Lts Pam-Glatt Compression Machine 37 Station 45 Station Legacy 61 station Cadpress IV 45 station with CFC 10 -30 RPM 20 -90 RPM 10 -70 RPM CIP Machinery Pam Pharmaceuticals Cadmach Machineries Auto coater 48 Inch 60 Inch 150 Kg 150 -350 Kg Saral Engineering Gansons Limited 3/19/2018 12

Capsule Manufacturing l l Blending Octagonal blender Encapsulation AF 90 T with latest features installed like Empty capsule sorter, Check weigher, Polisher, Filled Capsules and Metal detector Equipment Capacit Make y Capsule Filling 90000 Machine AF Cap/Hr 90 T Pam Pharmaceutical Octagonal Blender Global Pharmaceutical Equipment 3/19/2018 1250 L 13

Features of Formulation Plant q Individual processing areas serviced by dedicated AHU’s and differential pressure maintained to prevent cross – contamination q Tablets manufacturing areas : Temp. NMT 250 C and RH NMT 60% q Capsules manufacturing areas : Temp. NMT 250 C and RH NMT 45% q Manufacturing area classification complying to Grade D/Class 100, 000. q HEPA filtered air is provided to Manufacturing areas. Total 36 numbers of AHUs, 05 Numbers of Dehumidifiers and 07 Numbers of Ventilation Units are provided in the HVAC system. 3/19/2018 14

Quality Systems All activities as per laid down SOPs and protocols Training program (Induction, Need based, Systems and Incident based) Batch manufacturing through controlled Batch Manufacturing records Deviation Management, Change Control Management and CAPA Use of approved and validated test procedures with controlled work sheets Investigation of Out of specification results Structured stability program Handling of Market complaint and Product recall Annual Product Quality Review Self Inspection Quality Risk Management 3/19/2018 15

Thank You ! 3/19/2018 16